Seeking Alpha

  SciClone Pharmaceuticals, Inc. - NASDAQ

10/31/2014, 11:22 PM ET
  • DeFactoTrader | Send Message 2 Mar 2010

    SCLN Broke out of 3.50 resistance, +6% in after hours on beating earnings estimate.
      SCLN vs. ETF Alternatives
      Company Description
      SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.